TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

UNITED RES LABS

Pharmaceuticals
Generics

UNITED RES LABS is a generic drug manufacturer with 1 FDA-approved products.

2022
Since
1
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

COLESEVELAM HYDROCHLORIDE 2025-04-22
Labeling
COLESEVELAM HYDROCHLORIDE 2025-04-22
Labeling
COLESEVELAM HYDROCHLORIDE 2025-04-18
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...